Broadwood Capital INC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Broadwood Capital INC disclosed 6 US equity positions worth $1.9bn in its Q2 2026 13F filing. The largest position was MNST at 40.7% of the reported book, followed by STAA and AXON. Against the Q1 2026 filing, it opened 0 new positions, added to 1 and reduced 0 among the top 6 holdings.
What did Broadwood Capital INC own in Q2 2026? Top 6 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 40.7% | $779.3m | 8,107,796 | 0% | held |
| 2 | STAA STAAR SURGICAL CO | Healthcare | 24.2% | $462.6m | 16,123,842 | 0% | held |
| 3 | AXON AXON ENTERPRISE INC | Industrials | 20.3% | $388.8m | 693,504 | 0% | held |
| 4 | IWM ISHARES TR | 7.5% | $142.7m | 474,920 | 0% | held | |
| 5 | IMDX INSIGHT MOLECULAR DIA INC | 3.9% | $74.8m | 12,684,884 | 6% | added | |
| 6 | LCTX LINEAGE CELL THERAPEUTICS IN | 3.4% | $64.9m | 49,560,992 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.